Skip to menu Skip to content Skip to footer

The function of truncated MEK1 in a G2 phase cell cycle delay and in mitosis (2007-2009)

Abstract

In many cancers signaling through Ras-Raf-MEK-ERK is mutated. The effects of mutations of this pathway are proliferative and pro-survival advantages gained by cells with these mutations. The existence of another function for this important signaling pathway, or at least components of the pathway, will provide an entirely novel spectrum of possible outcomes for mutations of this pathway. It will also have major implication for therapies targeting the conventional Ras-Raf-MEK-ERK pathway as the outcomes may reflect not only influencing the activity of the conventional pathway but also the novel functions of this modified pathway.

Experts

Professor Brian Gabrielli

Honorary Professor
Mater Research Institute-UQ
Faculty of Health, Medicine and Behavioural Sciences
Brian Gabrielli
Brian Gabrielli